Dr Reddy's Laboratories has launched Bosutinib Tablets 400mg, a generic equivalent of Bosulif, in the United States, securing 180 days of market exclusivity. This strategic launch, developed in collaboration with MSN Laboratories, expands Dr Reddy's oncology portfolio and aims to make critical treatments more accessible. The reference brand, Bosulif, reported US sales of $253.8 million in the 12 months ending April 2026.

Gator Capital Management LLC significantly increased its stake in Primerica, Inc. (NYSE:PRI) by 1,311.3% during the fourth quarter, now holding 11,149 shares valued at $2.88 million. Other institutional investors also adjusted their positions, and Primerica reported strong quarterly earnings, surpassing analyst expectations for EPS and revenue. The company also announced a quarterly dividend of $1.20 per share.

Cardano Risk Management B.V. significantly increased its stake in Procter & Gamble (NYSE:PG) in the fourth quarter, purchasing an additional 8.7 million shares and bringing its total holdings to 9.5 million shares, valued at approximately $1.36 billion. Other institutional investors also made smaller additions, resulting in 65.77% of PG stock being owned by institutions. This news follows Procter & Gamble's better-than-expected earnings of $1.59 EPS on $21.24 billion in revenue and a dividend increase.

Boston Partners reduced its stake in eBay Inc. by 1.8% in Q4, selling 79,495 shares, but still holds 4.36 million shares valued at approximately $380 million. The e-commerce company received a consensus "Hold" rating from analysts with an average price target of $107.84, despite several firms raising their targets. eBay reported better-than-expected quarterly results, exceeding EPS and revenue estimates, and announced a quarterly dividend of $0.31 per share.

Boston Partners increased its stake in Gen Digital Inc. by 14.3% in the fourth quarter, purchasing an additional 1,954,712 shares to bring its total holdings to 15,644,289 shares, valued at approximately $425.3 million. The cybersecurity company reported strong quarterly results, with EPS of $0.67 and revenue of $1.28 billion, both exceeding estimates, and revenue growth of 27% year-over-year. Analysts currently rate the stock as a "Hold" with an average price target of $31.29, despite recent insider buying and selling activity.

This article provides financial information for Merck & Co., Inc. (MIL:1MRKX) on Euronext Milan, focusing on the number of shareholders. It details data provision sources and copyright information for the financial data presented on the TradingView platform.

Alchemi Wealth LLC has purchased 3,437 shares of American Express Company (AXP) stock, valued at approximately $1.27 million, marking a new position in the payment services company. American Express reported stronger-than-expected earnings of $4.28 per share and increased its FY 2026 EPS guidance, but revenue fell below estimates. Analysts generally hold a "Hold" rating for AXP, with an average price target of $359.05, and the company recently declared a quarterly dividend of $0.95 per share.

Boeing, once an aerospace leader, has faced scrutiny over shifting priorities from safety to cost-cutting after its 1997 merger with McDonnell Douglas. Whistleblowers have repeatedly raised concerns about manufacturing quality and safety, with one former quality control manager, John Barnett, found dead after flagging issues. These concerns are highlighted by the alleged technical failures leading to the crash of Air India Flight 171, a Boeing 787-8 Dreamliner with a history of electrical problems.

Columbus Hill Capital Management L.P. reduced its stake in Humana Inc. by 43.9% in Q4, but still holds 96,936 shares valued at approximately $24.83 million. Analysts have mixed views, with a consensus "Hold" rating and a target price of $291.35. Humana recently reported better-than-expected quarterly results and declared a quarterly dividend of $0.885 per share for July 31.

Cullen Capital Management LLC has decreased its stake in Lowe's Companies (LOW) by 2.3% in the fourth quarter, yet still holds 607,775 shares valued at approximately $146.6 million. Lowe's recently reported strong quarterly results, beating EPS and revenue estimates, and increased its quarterly dividend. Analysts currently rate Lowe's as a "Moderate Buy" with a consensus price target of $264.57.